Abstract:IL-1 (IL-1 alpha or IL-1 beta) is the prototypic "multifunctional" cytokine. Unlike the lymphocyte and colony stimulating growth factors, IL-1 affects nearly every cell type, and often in concert with other cytokines or small mediator molecules. Although some lymphocyte and colony stimulating growth factors may be therapeutically useful, IL-1 is a highly inflammatory cytokine and the margin between clinical benefit and unacceptable toxicity in humans is exceedingly narrow. In contrast, agents that reduce the production and/or activity of IL-1 are likely to have an impact on clinical medicine. In support of this concept, there is growing evidence that the production and activity of IL-1, particularly IL-1 beta, are tightly regulated events as if nature has placed specific "road blocks" to reduce the response to IL-1 during disease. In addition to controlling gene expression, synthesis and secretion, this regulation extends to surface receptors, soluble receptors and a receptor antagonist. Investigators have studied how production of the different members of the IL-1 family is controlled, the various biological activities of IL-1, the distinct and various functions of the IL-1 receptor (IL-1R) family and the complexity of intracellular signaling. Mice deficient in IL-1 beta, IL-1 beta converting enzyme (ICE) and IL-1R type I have also been studied. Humans have been injected with IL-1 (either IL-1 alpha or IL-1 beta) for enhancing bone marrow recovery and for cancer treatment. The IL-1 specific receptor antagonist (IL-1Ra) has also been tested in clinical trials.

Negative Regulator IL-1 Receptor 2 (IL-1R2) and Its Roles in Immune Regulation of Autoimmune Diseases

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

IL1R2 Acts as a Negative Regulator of Monocyte Recruitment During Inflammation

Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis

Biological functions and clinical implications of interleukin-34 in inflammatory diseases

The IL-1 family: regulators of immunity

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases

Research Progress on the Negative Regulatory Function of SIGIRR to IL-1R/TLRs Signal Pathway

Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist

Advances on role of interleukin-2 and its receptors in development of autoimmune diseases

[Roles of Interleukin-21 and Its Receptor in Autoimmune Diseases].

The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions

IL-20 Receptor Cytokines in Autoimmune Diseases

Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8

Loss of T follicular regulatory cell–derived IL-1R2 augments germinal center reactions via increased IL-1

Il-33, an Interleukin-1-Like Cytokine That Signals Via the Il-1 Receptor-Related Protein St2 and Induces T Helper Type 2-Associated Cytokines

Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

SIGIRR, a Negative Regulator of Toll-like Receptor–interleukin 1 Receptor Signaling

Functional Regulation of Interleukin-27 in Autoimmune Diseases

Role Of Interleukin-37 In Inflammatory And Autoimmune Diseases

IL-38: A New Player in Inflammatory Autoimmune Disorders.